Produktprogrammoptimierung mit Preisbündelung: Produktdesign, Bündelkonfiguration und Preisfindung
In: Bochumer Beiträge zur Unternehmensführung 80
7 Ergebnisse
Sortierung:
In: Bochumer Beiträge zur Unternehmensführung 80
In: Zeitschrift der Savigny-Stiftung für Rechtsgeschichte: Kanonistische Abteilung, Band 109, Heft 1, S. 227-237
ISSN: 2304-4896
Abstract
New insights and ideas for an edition of Huguccio's Summa decretorum. A critical edition of Huguccio's monumental and eminently influential Summa decretorum has long been an urgent desideratum of canonist research. The present contribution evaluates previous research conducted by Oldřich Přerovský (1924–2013) and presents the results of our own sample edition of parts of Huguccio's commentary on the pars prima of the Decretum Gratiani. In particular, we offer new insights into the Summa's complex manuscript tradition and propose a thorough revision of Přerovský's editorial methodology with the aim of relaunching the Huguccio edition in the future.
In: Population: revue bimestrielle de l'Institut National d'Etudes Démographiques. French edition, Band 45, Heft 3, S. 678
ISSN: 0718-6568, 1957-7966
In: Editiones Heidelbergenses Band 36
Background. Ciprofloxacin-resistant Campylobacter jejuni isolates obtained from infected patients in Australia have not been detected in studies of isolates from specific geographic areas. The Australian government has prohibited the use of fluoroquinolone in food-producing animals. To assess the impact of this policy, we have examined the antimicrobial susceptibility of isolates from 5 Australian states. Methods. We conducted a period-prevalence survey of the susceptibility of C. jejuni isolates to 10 antimicrobial agents. C. jejuni isolates obtained from 585 patients from 5 Australian states (Queensland, South Australia, Tasmania, Victoria, and Western Australia) were identified by means of notifiable disease databases and were systematically selected from September 2001 to August 2002. Results. Among locally acquired infections, only 2% of isolates (range, 0%-8% in different states) were resistant to ciprofloxacin. The locally acquired isolates also exhibited resistance to sulfisoxazole (55%), ampicillin (46%), roxithromycin (38%), tetracycline (7%), nalidixic acid (6%), chloramphenicol (3%), erythromycin (3%), gentamicin (2%), and kanamycin (0.2%). Treatment with antimicrobial agents in the 4 weeks before onset was not associated with ciprofloxacin resistance. Conclusions. The very low level of ciprofloxacin resistance in C. jejuni isolates likely reflects the success of Australia's policy of restricting use of fluoroquinolones in food-producing animals.
BASE
Background. Ciprofloxacin-resistant Campylobacter jejuni isolates obtained from infected patients in Australia have not been detected in studies of isolates from specific geographic areas. The Australian government has prohibited the use of fluoroquinolone in food-producing animals. To assess the impact of this policy, we have examined the antimicrobial susceptibility of isolates from 5 Australian states. Methods. We conducted a period-prevalence survey of the susceptibility of C. jejuni isolates to 10 antimicrobial agents. C. jejuni isolates obtained from 585 patients from 5 Australian states (Queensland, South Australia, Tasmania, Victoria, and Western Australia) were identified by means of notifiable disease databases and were systematically selected from September 2001 to August 2002. Results. Among locally acquired infections, only 2% of isolates (range, 0%-8% in different states) were resistant to ciprofloxacin. The locally acquired isolates also exhibited resistance to sulfisoxazole (55%), ampicillin (46%), roxithromycin (38%), tetracycline (7%), nalidixic acid (6%), chloramphenicol (3%), erythromycin (3%), gentamicin (2%), and kanamycin (0.2%). Treatment with antimicrobial agents in the 4 weeks before onset was not associated with ciprofloxacin resistance. Conclusions. The very low level of ciprofloxacin resistance in C. jejuni isolates likely reflects the success of Australia's policy of restricting use of fluoroquinolones in food-producing animals.
BASE
In: Bulletin of the World Health Organization: the international journal of public health, Band 84, Heft 12
ISSN: 0042-9686, 0366-4996, 0510-8659